Boxer Capital, LLC Buys Loxo Oncology Inc, Rocket Pharmaceuticals Inc, WAVE Life Sciences, Sells Concert Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Aradigm Corp

• New Purchases: LOXO, RCKT, DBVT, VKTX, RETA, SLDB, DERM, BLCM, NVUS,
• Added Positions: WVE, PTCT, CBAY, GTXI, MDCO, AVXS, ESPR, RIGL, AQXP, BGNE,
• Reduced Positions: IONS, RGLS,
• Sold Out: CNCE, ARDM,

For the details of Boxer Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Boxer+Capital%2C+LLC

1. AveXis Inc (AVXS) - 900,000 shares, 11.89% of the total portfolio. Shares added by 9.09%
2. BeiGene Ltd (BGNE) - 630,000 shares, 11.32% of the total portfolio. Shares added by 5.00%
3. PTC Therapeutics Inc (PTCT) - 2,600,000 shares, 7.5% of the total portfolio. Shares added by 48.57%
4. Esperion Therapeutics Inc (ESPR) - 900,000 shares, 6.96% of the total portfolio. Shares added by 12.50%
5. Odonate Therapeutics Inc (ODT) - 2,826,938 shares, 6.4% of the total portfolio. Shares added by 3.67%

Boxer Capital, LLC initiated holding in Loxo Oncology Inc. The purchase prices were between $84.18 and $132.87, with an estimated average price of $105.74. The stock is now traded at around $179.69. The impact to a portfolio due to this purchase was 4.94%. The holding were 400,000 shares as of 2018-03-31.

Boxer Capital, LLC initiated holding in Rocket Pharmaceuticals Inc. The purchase prices were between $10.44 and $19.19, with an estimated average price of $16.21. The stock is now traded at around $21.08. The impact to a portfolio due to this purchase was 3.94%. The holding were 1,966,051 shares as of 2018-03-31.

Boxer Capital, LLC initiated holding in DBV Technologies SA. The purchase prices were between $20.86 and $26.6, with an estimated average price of $23.63. The stock is now traded at around $21.43. The impact to a portfolio due to this purchase was 2.52%. The holding were 1,020,000 shares as of 2018-03-31.

Boxer Capital, LLC initiated holding in Viking Therapeutics Inc. The purchase prices were between $4.06 and $6.93, with an estimated average price of $5.51. The stock is now traded at around $10.62. The impact to a portfolio due to this purchase was 1.49%. The holding were 3,186,000 shares as of 2018-03-31.

Boxer Capital, LLC initiated holding in Reata Pharmaceuticals Inc. The purchase prices were between $20 and $30.19, with an estimated average price of $25.84. The stock is now traded at around $37.30. The impact to a portfolio due to this purchase was 0.71%. The holding were 325,000 shares as of 2018-03-31.

Boxer Capital, LLC initiated holding in Solid Biosciences Inc. The purchase prices were between $7.19 and $33.17, with an estimated average price of $22.57. The stock is now traded at around $24.45. The impact to a portfolio due to this purchase was 0.6%. The holding were 750,000 shares as of 2018-03-31.

Boxer Capital, LLC added to a holding in WAVE Life Sciences Ltd by 145.45%. The purchase prices were between $32.45 and $54.7, with an estimated average price of $42.04. The stock is now traded at around $48.45. The impact to a portfolio due to this purchase was 3.43%. The holding were 1,350,000 shares as of 2018-03-31.

Boxer Capital, LLC added to a holding in PTC Therapeutics Inc by 48.57%. The purchase prices were between $17.46 and $32.59, with an estimated average price of $25.34. The stock is now traded at around $37.95. The impact to a portfolio due to this purchase was 2.45%. The holding were 2,600,000 shares as of 2018-03-31.

Boxer Capital, LLC added to a holding in CymaBay Therapeutics Inc by 167.82%. The purchase prices were between $9 and $15.16, with an estimated average price of $12.42. The stock is now traded at around $12.38. The impact to a portfolio due to this purchase was 2.36%. The holding were 2,712,986 shares as of 2018-03-31.

Boxer Capital, LLC added to a holding in GTx Inc by 181.27%. The purchase prices were between $10.74 and $23.25, with an estimated average price of $15.91. The stock is now traded at around $18.34. The impact to a portfolio due to this purchase was 1.95%. The holding were 1,590,000 shares as of 2018-03-31.

Boxer Capital, LLC added to a holding in The Medicines Co by 66.67%. The purchase prices were between $24.83 and $35.48, with an estimated average price of $31.25. The stock is now traded at around $36.21. The impact to a portfolio due to this purchase was 1.76%. The holding were 1,250,000 shares as of 2018-03-31.

Boxer Capital, LLC added to a holding in Rigel Pharmaceuticals Inc by 63.69%. The purchase prices were between $3.54 and $4.54, with an estimated average price of $4. The stock is now traded at around $3.22. The impact to a portfolio due to this purchase was 0.76%. The holding were 5,140,000 shares as of 2018-03-31.

Boxer Capital, LLC sold out a holding in Concert Pharmaceuticals Inc. The sale prices were between $19.24 and $28.03, with an estimated average price of $22.24.

Boxer Capital, LLC sold out a holding in Aradigm Corp. The sale prices were between $1.06 and $6.51, with an estimated average price of $1.92.